LATISSE® is a growth treatment for hypotrichosis. People with this condition often experience inadequate or sparse eyelash growth. It is the only FDA-approved treatment that has been clinically proven to help grow lashes. It is also the only lash growth product of its kind available by prescription, which means you will need to meet with a physician to determine if it is the best treatment for you.
LATISSE® solution is a nightly treatment applied to the base of your upper eyelashes, as instructed by your doctor. You should start to see increased length in as little as 4 weeks, and full results in approximately 16 weeks. It’s not an illusion of growth—it’s real lash growth!
LATISSE® contains an active ingredient called Bimatoprost that makes this lash growth possible. LATISSE® is believed to affect the growth (anagen) phase of the eyelash hair cycle by increasing the length of this phase, as well as the number of hairs growing during this phase.
LATISSE® was created by Allergan. In 2001, they developed a medicated eye drop meant for treating elevated intraocular pressure. Many patients using this medication also reported growing longer, fuller, and darker lashes as a side effect. Allergan began to study the medication’s active ingredient, bimatoprost, as a substance specifically for growing lashes. After clinical trials were run, LATISSE® was approved by the FDA in 2008.
Contact us for more information on LATISSE® eyelash growth treatment, and whether or not it may be right for you.